Mott, David J. http://orcid.org/0000-0001-5959-8447
Hampson, Grace http://orcid.org/0000-0002-2019-1268
Llewelyn, Martin J. http://orcid.org/0000-0002-6811-1124
Mestre-Ferrandiz, Jorge http://orcid.org/0000-0003-0529-1321
Hopkins, Michael M. http://orcid.org/0000-0002-8401-6573
Funding for this research was provided by:
UK Research and Innovation (MR/N014316/1)
Article History
First Online: 20 September 2019
Compliance with Ethical Standards
:
: We acknowledge financial support from the UK cross council Tackling AMR (Grant Ref: MR/N014316/1), the University of Sussex Business School and the Office of Health Economics. The Office of Health Economics, is a registered charity that receives funding from a variety of sources, including the Association of the British Pharmaceutical Industry.
: DJM, GH, MJL, JM-F and MMH have no conflicts of interest that are relevant to this manuscript.
: Ethical approval for the survey was sought and obtained from the University of Sussex (reference: ER/FL49/3) and the study was performed in accordance with the ethical standards of the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the study.